Walleye Capital’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-87,705
| Closed | -$330K | – | 2177 |
|
|
2025
Q1 | $330K | Buy |
87,705
+20,698
| +31% | +$77.8K | ﹤0.01% | 1230 |
|
|
2024
Q4 | $391K | Buy |
+67,007
| New | +$391K | ﹤0.01% | 1261 |
|
|
2024
Q2 | – | Sell |
-11,966
| Closed | -$135K | – | 2879 |
|
|
2024
Q1 | $135K | Sell |
11,966
-178
| -1% | -$2.02K | ﹤0.01% | 1928 |
|
|
2023
Q4 | $170K | Sell |
12,144
-144,885
| -92% | -$2.03M | ﹤0.01% | 1514 |
|
|
2023
Q3 | $1.94M | Buy |
+157,029
| New | +$1.94M | 0.01% | 663 |
|
|
2023
Q2 | – | Sell |
-182,337
| Closed | -$633K | – | 2630 |
|
|
2023
Q1 | $633K | Buy |
182,337
+151,036
| +483% | +$524K | 0.01% | 906 |
|
|
2022
Q4 | $76.7K | Buy |
+31,301
| New | +$76.7K | ﹤0.01% | 1576 |
|
|
2022
Q2 | – | Sell |
-71,414
| Closed | -$304K | – | 2564 |
|
|
2022
Q1 | $304K | Sell |
71,414
-119,109
| -63% | -$507K | 0.01% | 1263 |
|
|
2021
Q4 | $1.78M | Buy |
+190,523
| New | +$1.78M | 0.06% | 350 |
|